A	B	C
1	main
2		Brand Name	INCB8696
3		Generic Name
4		Indication	Multiple Sclerosis
5		Mechanism	CCR2 Antagonist
6		Administration
7		Economics	Possibly 10%; Collaboration with Pfizer
8		IP
9		History
10		Clinical Trials
11			Phase I
12			H1 2007: initiation